美国居住是否是阿尔茨海默病的危险因素?
Poul F Høilund-Carlsen1,2, Abass Alavi3, Tommaso Costa4,5
1Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Journal of Alzheimer's disease : JAD
|July 4, 2025
概括
减少阿尔茨海默病 (AD) 风险因素至关重要. 医疗保险和医疗补助服务中心应该重新考虑粉样蛋白PET扫描报销,并支持FDG-PET扫描以更好地诊断AD.
科学领域:
- 神经学 神经学
- 医疗成像医学成像
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默病 (AD) 影响全球数百万人,患病率因地区而异 (例如,美国为2.1%,英国为0.7%).
- 目前的诊断方法包括降低风险因素和成像技术.
关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.带来了一些令人惊的东西.粉胺-PET是一种粉胺.诊断 诊断 诊断 诊断 诊断 诊断没有的,没有的,没有的.莱卡内马布 (lecanemab) 是一个患病率的流行情况.风险因素的风险因素是什么更多相关视频
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.4K
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.1K
相关概念视频
Alzheimer's Disease: Overview
675
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
675
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Dementia
173
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
173
Psychoneuroimmunology: Diabetes and Cancer
66
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
66
Cognitive Development During Adulthood
296
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
296
Psychological and Sociocultural Causes of Schizophrenia
192
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
192
